Funds holding Evommune Inc
ISIN US30054Y1073 · United States
- Fund holders
- 116
- Of which ETFs
- 18 98 other funds
- Value held
- 83.8M $
- Share of capital
- 17.1 % of 36.3M shares on Aug 4, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 248 | 5.8K $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 248 | 3.3K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Strategic Allocation: Conservative Fund American Century Strategic Asset Allocations Inc | 228 | 2.6K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 163 | 1.8K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Fidelity Enhanced Small Cap Growth ETF Fidelity Covington Trust | 120 | 1.6K $ | 0.03 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 68 | 903.7 $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 52 | 691.1 $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 34 | 451.9 $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 31 | 412 $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 22 | 292.4 $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 21 | 279.1 $ | 0.00 % | as of Jun 30, 2026 ↗ | |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 19 | 252.5 $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 11 | 123.8 $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 10 | 232.3 $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 4 | 53.2 $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 3 | 69.7 $ | 0.01 % | 0.00 % | as of May 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 0.70 % | as of Jun 30, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 0.38 % | as of Jul 31, 2026 ↗ |
| JPMorgan Small Cap Growth Fund JPMorgan Trust II | 0.28 % | as of Jun 30, 2026 ↗ |
| American Century Small Cap Growth Insights ETF American Century ETF Trust | 0.18 % | as of May 31, 2026 ↗ |
| Multi-Manager Small Cap Equity Strategies Fund COLUMBIA FUNDS SERIES TRUST I | 0.17 % | as of May 31, 2026 ↗ |
| Small Cap Growth Fund VALIC Co I | 0.17 % | as of May 31, 2026 ↗ |
| JPMorgan Small Cap Blend Fund JPMorgan Trust I | 0.14 % | as of Jun 30, 2026 ↗ |
| Federated Hermes Kaufmann Small Cap Fund Federated Hermes Equity Funds | 0.13 % | as of Jul 31, 2026 ↗ |
| Small Cap Growth Fund American Century Mutual Funds, Inc. | 0.11 % | as of Jul 31, 2026 ↗ |
| T. Rowe Price New Horizons Fund, Inc. T. ROWE PRICE NEW HORIZONS FUND, INC. | 0.06 % | as of Jun 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 116 | +20 | 6,210,145 | +31.9 % |
| 2026Q2 | 96 | +70 | 4,708,237 | +23.6 % |
| 2026Q1 | 26 | 3,809,539 |
Institutional managers
79 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| EQT Fund Management S.a r.l. | 4,929,633 | 113.3M $ | as of Mar 31, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | 3,494,638 | 80.3M $ | as of Mar 31, 2026 |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,926,943 | 44.3M $ | as of Mar 31, 2026 |
| ANDERA PARTNERS | 1,897,362 | 43.6M $ | as of Mar 31, 2026 |
| RTW INVESTMENTS, LP | 1,502,235 | 34.5M $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 1,459,420 | 32.1M $ | as of Mar 31, 2026 |
| MPM BIOIMPACT LLC | 1,455,863 | 33.5M $ | as of Mar 31, 2026 |
| Nan Fung Group Holdings Ltd | 1,441,032 | 33.1M $ | as of Mar 31, 2026 |
| SymBiosis Capital Partners, LLC | 1,280,778 | 29.4M $ | as of Mar 31, 2026 |
| EVENTIDE ASSET MANAGEMENT, LLC | 1,209,129 | 27.8M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1,119,021 | 25.7K $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 896,700 | 20.6M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 879,728 | 20.2M $ | as of Mar 31, 2026 |
| BAKER BROS. ADVISORS LP | 847,390 | 19.5M $ | as of Mar 31, 2026 |
| Alyeska Investment Group, L.P. | 726,362 | 16.7M $ | as of Mar 31, 2026 |
| Defilade Capital Management, L.P. | 678,589 | 15.6M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 673,571 | 15.5M $ | as of Mar 31, 2026 |
| Kynam Capital Management, LP | 625,496 | 14.4M $ | as of Mar 31, 2026 |
| SECTORAL ASSET MANAGEMENT INC | 589,005 | 13.5M $ | as of Mar 31, 2026 |
| Verition Fund Management LLC | 549,991 | 12.6M $ | as of Mar 31, 2026 |
| AMERICAN CENTURY COMPANIES INC | 492,938 | 11.3M $ | as of Mar 31, 2026 |
| PERCEPTIVE ADVISORS LLC | 448,350 | 10.3M $ | as of Mar 31, 2026 |
| Velan Capital Investment Management LP | 446,255 | 10.3M $ | as of Mar 31, 2026 |
| Freestone Grove Partners LP | 337,291 | 7.8M $ | as of Mar 31, 2026 |
| GREAT POINT PARTNERS LLC | 325,000 | 7.5M $ | as of Mar 31, 2026 |
Declared shareholders of Evommune Inc
There are 3 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| T. Rowe Price Associates, Inc. | 5.40 % | 1,940,939 | as of Jun 30, 2026 · SCHEDULE 13G |
| Point72 Asset Management, L.P. and 2 others | 5.30 % | 1,910,489 | as of Jul 15, 2026 · SCHEDULE 13G |
| Andera Partners and 3 others | 3.90 % | 1,391,990 | as of Jun 30, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding Evommune Inc". https://titelia.com/en/stocks/evommune-inc-US30054Y1073